RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $436,142 | -16.5% | 26,242 | -6.0% | 0.00% | 0.0% |
| Q2 2023 | $522,141 | -21.9% | 27,922 | -23.4% | 0.00% | 0.0% |
| Q1 2023 | $668,858 | -4.5% | 36,450 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $700,524 | -5.1% | 35,380 | +15.4% | 0.00% | 0.0% |
| Q3 2022 | $738,000 | +29.5% | 30,669 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $570,000 | +1.6% | 31,207 | +22.3% | 0.00% | 0.0% |
| Q1 2022 | $561,000 | -44.8% | 25,525 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $1,017,000 | +21.8% | 27,700 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $835,000 | +6.0% | 26,892 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $788,000 | +114.7% | 24,777 | +49.8% | 0.00% | – |
| Q1 2021 | $367,000 | +12.2% | 16,542 | 0.0% | 0.00% | – |
| Q4 2020 | $327,000 | -38.6% | 16,542 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $533,000 | +11.0% | 16,542 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $480,000 | +841.2% | 16,542 | +588.7% | 0.00% | – |
| Q1 2020 | $51,000 | -22.7% | 2,402 | +1.2% | 0.00% | – |
| Q4 2019 | $66,000 | – | 2,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |